• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术前几周进行红细胞单采术:计划性自体输血中促红细胞生成素治疗的替代方法

[Erythrocytapheresis a few weeks before surgery: an alternative to erythropoietin treatment in programmed autologous transfusion].

作者信息

Bernière J, Gerota I

机构信息

Département Anesthésiologie, Hôpital Trousseau, Paris.

出版信息

Cah Anesthesiol. 1996;44(4):303-8.

PMID:9033827
Abstract

The usual methods like hypotension, isovolaemic haemodilution, autologous transfusion and peri-operative blood salvage may significantly reduce the need for homologous blood transfusion in haemorrhagic surgery and also the risk of transmitting infectious agents. Erythropoietin (EPO) is now available and is used to stimulate red cell regeneration in pre-operative autologous blood donation. In acute anaemia, many studies have shown that the stimulation of endogenous erythropoietin production could be very high and accelerate red blood cell production. Taking higher quantities of blood than usual induces a secretion of endogenous erythropoietin, and could be an alternative for the utilization of exogenous EPO in autologous blood donation.

摘要

诸如低血压、等容性血液稀释、自体输血和围手术期血液回收等常用方法,可显著减少出血性手术中对异体输血的需求,同时降低传播感染因子的风险。促红细胞生成素(EPO)现已可用,并用于术前自体献血中刺激红细胞再生。在急性贫血中,许多研究表明,内源性促红细胞生成素的分泌可非常高,并加速红细胞生成。采集比平常更多的血液可诱导内源性促红细胞生成素的分泌,这可能是在自体献血中替代使用外源性EPO的一种方法。

相似文献

1
[Erythrocytapheresis a few weeks before surgery: an alternative to erythropoietin treatment in programmed autologous transfusion].手术前几周进行红细胞单采术:计划性自体输血中促红细胞生成素治疗的替代方法
Cah Anesthesiol. 1996;44(4):303-8.
2
Anemia in the critically ill.危重症患者的贫血
Crit Care Clin. 2004 Apr;20(2):159-78. doi: 10.1016/j.ccc.2004.01.002.
3
[Effect of recombinant human erythropoietin on autologous blood pre-donation in open heart surgery].
Kyobu Geka. 1991 Aug;44(9):728-31.
4
Autologous transfusion and other approaches to reduce allogeneic blood exposure.
Baillieres Best Pract Res Clin Haematol. 2000 Dec;13(4):533-47. doi: 10.1053/beha.2000.0098.
5
Minimizing perioperative homologous blood exposure with recombinant human erythropoietin.使用重组人促红细胞生成素使围手术期异体血暴露降至最低。
Surg Annu. 1993;25 Pt 1:83-99.
6
Enhancing the efficacy of preoperative autologous blood donation by erythropoietin.
Transfus Sci. 1994 Jun;15(2):171-7. doi: 10.1016/0955-3886(94)90092-2.
7
Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease.
Am J Med. 1991 Mar;90(3):398-400.
8
[Analysis of mechanism of increased platelet counts during preoperative autologous blood donation].[术前自体献血期间血小板计数增加的机制分析]
Rinsho Byori. 1997 Jan;45(1):72-6.
9
An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.个性化的术前血液保存方案可提高择期全髋关节或膝关节置换术中的术前血红蛋白水平,并减少输血需求。
Transfus Med. 2009 Feb;19(1):35-42. doi: 10.1111/j.1365-3148.2009.00908.x.
10
Optimizing autologous blood donation by recombinant human erythropoietin (rhu-EPO) and interleukin 3 (IL-3).通过重组人促红细胞生成素(rhu-EPO)和白细胞介素3(IL-3)优化自体献血。
Behring Inst Mitt. 1991 Dec(90):75-85.